Reovirus oncolysis of human breast cancer

Human Gene Therapy
Kara L NormanPatrick W K Lee

Abstract

We have previously shown that human reovirus replication is restricted to cells with an activated Ras pathway, and that reovirus could be used as an effective oncolytic agent against human glioblastoma xenografts. This study examines in more detail the feasibility of reovirus as a therapeutic for breast cancer, a subset of cancer in which direct activating mutations in the ras proto-oncogene are rare, and yet where unregulated stimulation of Ras signaling pathways is important in the pathogenesis of the disease. We demonstrate herein the efficient lysis of breast tumor-derived cell lines by the virus, whereas normal breast cells resist infection in vitro. In vivo studies of reovirus breast cancer therapy reveal that viral administration could cause tumor regression in an MDA-MB-435S mammary fat pad model in severe combined immunodeficient mice. Reovirus could also effect regression of tumors remote from the injection site in an MDA-MB-468 bilateral tumor model, raising the possibility of systemic therapy of breast cancer by the oncolytic agent. Finally, the ability of reovirus to act against primary breast tumor samples not propagated as cell lines was evaluated; we found that reovirus could indeed replicate in ex vivo surgical...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P CarterH M Shepard
Sep 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·M H KrausS A Aaronson
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·M A WebsterW J Muller
Sep 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F H ValoneM Mrozek-Orlowski
Dec 1, 1994·Cellular and Molecular Neurobiology·K Rózsa, J Salánki
Jan 1, 1994·Molecular and Cellular Biology·S K MuthuswamyW J Muller
Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BaselgaL Norton
Jan 1, 1996·Breast Cancer Research and Treatment·J E Price
Nov 13, 1998·Science·M C CoffeyP W Lee
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Apr 24, 2001·Journal of Cancer Research and Clinical Oncology·D ReissigF D Böhmer
Jun 21, 2001·Journal of the National Cancer Institute·M E WilcoxP A Forsyth

❮ Previous
Next ❯

Citations

Dec 1, 2006·Apoptosis : an International Journal on Programmed Cell Death·Penny Clarke, Kenneth L Tyler
Feb 8, 2008·Breast Cancer Research and Treatment·Kathryn A SkeldingDarren R Shafren
Feb 15, 2005·Current Surgery·Maren M Chan, J Dirk Iglehart
Aug 13, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Timothy P CripePatrick Wk Lee
Mar 19, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Paola MarcatoPatrick W K Lee
Mar 21, 2001·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·E HovigE B Smeland
Sep 4, 2003·The Cancer Journal·E Antonio ChioccaGiulia Fulci
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jian QiaoKevin Harrington
Jan 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Timothy KottkeRichard G Vile
Oct 6, 2012·Molecular Cancer Research : MCR·Radhashree MaitraSanjay Goel
Apr 7, 2010·The Journal of Clinical Investigation·Timothy KottkeRichard Vile
Aug 31, 2004·BMC Cell Biology·Jinsong ShengDonald H Rubin
Jul 20, 2010·Immunotherapy·Nicolas BoisgeraultMarc Gregoire
Nov 3, 2011·Bone Marrow Research·Chandini M Thirukkumaran, Don G Morris
Apr 9, 2014·BioMed Research International·Hung-Chuan ChiuHung-Jen Liu
Jul 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kara L NormanPatrick W K Lee
Jun 21, 2014·Future Oncology·Meaghan L KhanMitesh J Borad
Jul 5, 2002·Journal of Virology·Joseph W GoldenLeslie A Schiff
Dec 30, 2015·Viruses·Vera KempDiana J M van den Wollenberg
Jun 17, 2009·Expert Opinion on Biological Therapy·Kevin KellyMonica Mita
Nov 18, 2008·Expert Opinion on Investigational Drugs·Timothy A YapJohann S Debono
Jul 19, 2011·Gynecologic Oncology·Andreas D HartkopfUlrich M Lauer
Feb 5, 2015·The Journal of Veterinary Medical Science·Masaya IgaseTakuya Mizuno
Nov 8, 2008·The American Journal of Pathology·Faris FarassatiAndreas Kurtz
Feb 18, 2004·Clinical Lung Cancer·Liang YouDavid M Jablons
Jun 28, 2008·Clinical Oncology : a Journal of the Royal College of Radiologists·C CominsH Pandha
Aug 25, 2010·Pediatric Blood & Cancer·Adrienne M HammillTimothy P Cripe
Oct 17, 2014·Veterinary and Comparative Oncology·C C HwangT Mizuno
Dec 29, 2005·Trends in Biotechnology·Daniel H PalmerVivien Mautner
May 31, 2002·Expert Opinion on Pharmacotherapy·Walter Kolch
Apr 19, 2015·Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'oto-rhino-laryngologie Et De Chirurgie Cervico-faciale·Timothy CooperHadi Seikaly
Jun 23, 2005·Drug Discovery Today·Kara L Norman, Patrick W K Lee
Feb 20, 2015·Investigational New Drugs·Romit ChakrabartyMatt Coffey
Jan 1, 2014·Uirusu·Takeshi Kobayashi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

© 2022 Meta ULC. All rights reserved